Actavis Acquires Indian Drug Facility | Chemical & Engineering News
Volume 85 Issue 2 | p. 28 | Concentrates
Issue Date: January 8, 2007

Actavis Acquires Indian Drug Facility

Department: Business | Collection: Sustainability

Icelandic generic drugmaker Actavis has bought a manufacturing plant in Alathur, India, from the Indian firm Grandix Pharmaceuticals. The site manufactures solid oral dosage formulations of drugs. Actavis notes that it recently opened an active pharmaceutical ingredient development facility in India, and in 2005 it acquired Lotus Laboratories, a Bangalore-based contract research organization.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment